Novavax’s Covid-19 vaccine could find its niche as a booster shot, but questions linger around its safety and production.
The UK’s decision to opt out of the European Union (EU) has set numerous industries up for disruptions especially after the official exit in January 2020.
The pharmaceutical supply chains were disrupted due to the Covid-19 pandemic creating a shortage of raw materials and ancillary supplies required for clinical trials.
External suppliers are used extensively throughout the pharma industry, but how can new client-supplier relationships be managed and defined most effectively? Pfizer's senior director for drug product supply external strategy Francis Dumont makes the case...
AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the Phase III CASPIAN trial in first-line extensive-stage small cell lung cancer (SCLC).
Novartis reported that the first clinical trial in its Phase III PLATINUM programme for QMF149 has met primary and key secondary endpoints in people with inadequately controlled asthma; and The National Institute of Allergy and...